) With a Gross Domestic Product (GDP) of about $1,140 per capita, and a Human Development Index (HDI) ranking of 121 out of 175, Vietnam is one of the least developed nations in the world. Similarly, Laos, with a GDP of $850 and a HDI ranking of 136 out of 175, is another of the least developed nations. Both countries possess a high tropical biodiversity. Yet these rich biodiversities are under threat: the rate of deforestation is estimated at 600 sq km/year for Vietnam, and 1,00 sq km/year for Laos. Clearly, whatever tropical biodiversity each of these two countries still has must be protected, and, as a resource, must be investigated for its economic potential. A demonstration that these forests could provide new medicines and general revenue for the country would help strengthen the cause of protecting these highly diverse ecosystems. In view of a long- standing relationship that exists between the organization of the Principal Investigator, the Program for Collaborative Research in the Pharmaceutical Sciences at the University of Illinois at Chicago (PCRPS/LAC), and two research institutions in Vietnam, the National Center for Natural Sciences and Technology and the Cuc Phuong National Park, on the one hand, and between the PCRPS/UIC and the Research Institute for Medicinal Plants in Laos, on the other, a proposal is made to carry out a collaborative study for an initial period of five years. The long-term objectives of the study are (1) to undertake a documented inventory of tropical forest plant diversity and medicinal plant use in these countries (Cuc Phuong National Park in Vietnam, and ethnobotanical surveys of selective tribal groups in Laos); (2) to discovered novel biologically active molecules from plants from both countries as possible candidates for drug development in the treatment of malaria, viral diseases (including AIDS) and CNS-related diseases; and (3) to improve the standard of living of the members of the tribal communities studied, and of the countries in general, through community education and biomass production of plants that have been identified as having promising economic potential, particularly medicinal potential. An industrial partner, Glaxo Wellcome Research and Development Limited, Stevenage, UK, will strengthen this PCRPS/UIC-based International Cooperative Biodiversity Group (ICBG).

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01TW001015-05
Application #
6530083
Study Section
Special Emphasis Panel (ZCA1-RLB-3 (M1))
Program Officer
Katz, Flora N
Project Start
1998-09-30
Project End
2003-09-29
Budget Start
2002-09-30
Budget End
2003-09-29
Support Year
5
Fiscal Year
2002
Total Cost
$800,000
Indirect Cost
Name
University of Illinois at Chicago
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Guan, Yifu; Wang, Dongying; Tan, Ghee T et al. (2016) Litsea Species as Potential Antiviral Plant Sources. Am J Chin Med 44:275-90
Guan, Yi-Fu; Song, Xun; Qiu, Ming-Hua et al. (2016) Bioassay-Guided Isolation and Structural Modification of the Anti-TB Resorcinols from Ardisia gigantifolia. Chem Biol Drug Des 88:293-301
Elkington, Bethany G; Sydara, Kongmany; Newsome, Andrew et al. (2014) New finding of an anti-TB compound in the genus Marsypopetalum (Annonaceae) from a traditional herbal remedy of Laos. J Ethnopharmacol 151:903-11
Pan, Wenhui; Liu, Kanglun; Guan, Yifu et al. (2014) Bioactive compounds from Vitex leptobotrys. J Nat Prod 77:663-7
Elkington, Bethany G; Sydara, Kongmany; Hartmann, John F et al. (2013) Folk Epidemiology Recorded in Palm Leaf Manuscripts of Laos. J Lao Stud 3:1-14
Soejarto, D D; Gyllenhaal, C; Kadushin, M R et al. (2012) An ethnobotanical survey of medicinal plants of Laos toward the discovery of bioactive compounds as potential candidates for pharmaceutical development. Pharm Biol 50:42-60
Gyllenhaal, C; Kadushin, M R; Southavong, B et al. (2012) Ethnobotanical approach versus random approach in the search for new bioactive compounds: support of a hypothesis. Pharm Biol 50:30-41
Truong, Ngan B; Pham, Cuong V; Doan, Huong T M et al. (2011) Antituberculosis cycloartane triterpenoids from Radermachera boniana. J Nat Prod 74:1318-22
Chlipala, George E; Pham, Huu Tri; Nguyen, Van Hung et al. (2010) Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam. J Nat Prod 73:784-7
Elkington, Bethany G; Southavong, Bounhong; Sydara, Kongmany et al. (2009) Biological evaluation of plants of Laos used in the treatment of tuberculosis in Lao traditional medicine. Pharm Biol 47:26-33

Showing the most recent 10 out of 27 publications